NASDAQ
ALVO
Last Price
US $3.30
KEY FIGURES
MKT CAP
$1.1B
EPS
TTM
$-0.24
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
1.95x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Alvotech cash flow to debt ratio of -3.46% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Alvotech's free cash flow has increased -60.98% from $-293.84M last year to $-114.67M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Alvotech's debt to equity ratio is -5.16, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
Alvotech's debt to equity ratio is -5.16, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Net debt/EBITDA.
Alvotech has a net debt to EBITDA ratio of 3.95x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Alvotech earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Alvotech's profit margin has increased (-69.52%) in the last year from -47.35% to -14.43%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Alvotech's short-term assets of $574.01M exceed its short-term liabilities of $304.08M
Decreasing performance - ROA.
Alvotech's return on assets of -5.68% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
Alvotech's return on equity of 35.22%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Alvotech's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Alvotech had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Alvotech has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Alvotech has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Alvotech's yearly earnings has increased -112.04% since last year from $-231.86M to $27.92M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Alvotech's yearly revenue has increased 19.74% since last year from $489.68M to $586.32M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -11.66% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Alvotech's 3-year revenue CAGR of 91.85% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Alvotech had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Alvotech had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Alvotech has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Alvotech has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Alvotech is overvalued relative to its fair value price of 3.17 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Alvotech has an EV/EBITDA ratio of 7.40x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Alvotech has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Alvotech has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
Alvotech has a price-to-sales ratio of 1.95x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
35.22%
Return on equity
ROIC: -11.66%
Valuation History
-11.5X
Price to Earnings
EV/EBITDA: 48.3X
Cash flow
Profit margin
54.49%
(FY vs FY)
EBITDA Y/Y
-
(FY vs FY)
Cash flow Y/Y
-5.53%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $3.30
—
Default assumptions
EBITDA Multiple
Fair Value
Market $3.30
-3.94%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.